BWAY - MCAP CO - BrainsWay Ltd.

This daily price chart for BrainsWay Ltd. (BWAY) on GURU.Markets reflects a level of 0.53, while the company's pricing power is constrained by the budgets of private centers. The business relies on its patented Deep TMS method for treating OCD and depression, expanding its network of clinics. The production of high-tech helmets is concentrated in the US and Israel, ensuring steady growth of the equipment fleet.

Market capitalization reflects the aggregate value of all the issuer's shares, determining the current scale of BrainsWay Ltd. (BWAY) in the eyes of investors. By analyzing the dynamics of the company's market value, one can track the redistribution of capital within the medtech sector. This metric is calculated by multiplying the current share price by the total number of outstanding shares, reaching a value of 0.53. Growth in this metric confirms market confidence in the commercialization of non-invasive brain stimulation systems. The valuation depends directly on clinic demand for depression therapy equipment.